KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Should Stereotactic Ablative Radiotherapy Be Used for Oligometastatic Disease?

Robert A Olson, David A Palma

NEJM Evid 1(12) EVIDtt2200209

PMID38319839
PMCID-
DOI10.1056/EVIDtt2200209
发表日期2024-02-06
摘要

摘要

Should SABR Be Used for Oligometastatic Disease?The efficacy of stereotactic ablative radiotherapy in the oligometastatic setting has not been shown in phase 3 randomized controlled trials for breast (or many other) cancers. We review the evidence base and propose a trial to address the question, should stereotactic ablative radiotherapy be used for oligometastatic disease?

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。